Journal of Mathematics (Jan 2024)

A Two-Objective Model for the Multilevel Supply Chain of Blood Products with the Approach of Reducing the Rate of Contagion under the (COVID-19) Epidemic Outbreak Conditions

  • Abolfazl Moghimi Esfandabadi,
  • Davood Shishebori,
  • Mohammad-Bagher Fakhrzad,
  • Hassan Khademi Zare

DOI
https://doi.org/10.1155/2024/9986541
Journal volume & issue
Vol. 2024

Abstract

Read online

The conditions of the coronavirus epidemic have put much pressure on the healthcare system. This disease has hurt the blood supply through the reduction of blood donation and the reduction of access to suitable collection facilities due to dysfunction. Considering the importance of the subject, the purpose of this paper is to design a two-level supply chain network for blood products with the approach of reducing costs and the rate of contagion under the conditions of epidemic outbreaks (COVID-19). After examining the solution methods for multilevel supply chain networks of blood products under the conditions of the spread of the COVID-19 virus, three exact solution methods, including LP-metric, an improved version of the augmented ε-constraint (AUGMECON2), and an improved weighted Chebyshev, are proposed. They are used to solve the model in small dimensions. In order to compare the methods in the obtained solutions, several numerical examples of different sizes are generated and solved. Then, using the statistical assumption test, the obtained results are compared in all numerical examples by Tukey’s technique. Also, the TOPSIS is applied to select the best method. Finally, in order to investigate the reaction of the objectives to the changes in the contagion probability parameter, a sensitivity analysis has been performed. The results emphasize that improving the performance of the blood supply chain (BSC) can lead to a reduction in BSC costs and improved service to patients. Also, the adaptation of different components of the BSC and regular coordination between them play an efficient role in controlling and improving this disease and reducing the costs of the BSC. Also, receiving the plasma product of recovered people from type (II) donors can play a vital role in reducing the percentage of disease transmission.